Stockscreener 앱 받기
44.67
0.79%
0.35
Qiagen Nv 주식(QGEN)의 최신 뉴스
August 2025 Options Now Available For Qiagen (QGEN) - Nasdaq
Qiagen Announces AFM Notification on BlackRock Shareholding - TipRanks
Qiagen Highlights BlackRock’s Indirect Stake in Voting Rights Disclosure - TipRanks
State Street Corp Boosts Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret - MSN
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
QIAGEN Launches Ingenuity Pathway Analysis Interpret - Marketscreener.com
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data - Business Wire
Public Employees Retirement System of Ohio Buys Shares of 214,400 Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Shares Bought by Barclays PLC - MarketBeat
QIAGEN Unveils AI-Powered IPA Interpret Platform to Transform Biological Data Analysis - StockTitan
Qiagen (NYSE:QGEN) Stock Holdings Lifted by XTX Topco Ltd - MarketBeat
Qiagen (NYSE:QGEN) Given "Buy" Rating at Jefferies Financial Group - MarketBeat
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly - Simply Wall St
Point72 Asset Management L.P. Trims Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
Janus Henderson Group PLC Reduces Holdings in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements - MSN
Qiagen shares get Buy rating, $54 target from Jefferies By Investing.com - Investing.com Canada
Qiagen shares get Buy rating, $54 target from Jefferies - Investing.com
Jefferies Starts Qiagen NV (QGEN) at Buy - StreetInsider.com
QIAGEN Wins FDA Clearance of QIAstat-Dx Meningitis/Encephalitis Panel - MPO-mag
Quantinno Capital Management LP Has $3.56 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
25,658 Shares in Qiagen (NYSE:QGEN) Acquired by Verition Fund Management LLC - MarketBeat
Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound? - MSN
Fmr LLC Raises Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now? - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 321,182 Shares of Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation - Silicon Canals
Proteinase K Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Edgestream Partners L.P. Reduces Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Parkman Healthcare Partners LLC Decreases Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
219,245 Shares in Qiagen (NYSE:QGEN) Purchased by Holocene Advisors LP - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Point72 Hong Kong Ltd Boosts Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Stock Holdings Increased by Public Sector Pension Investment Board - MarketBeat
Qiagen (NYSE:QGEN) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
FY2024 Earnings Forecast for Qiagen Issued By Zacks Research - MarketBeat
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
Martingale Asset Management L P Decreases Position in Qiagen (NYSE:QGEN) - MarketBeat
QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site - Yahoo Finance
QIAGEN announces new site in Barcelona for QIAstat-Dx operations - Medical Device Network
QIAGEN introduces new custom tools for microbial analysis - Yahoo Finance
Quantbot Technologies LP Has $3.31 Million Stake in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Expands Diagnostic Operations with New 8,000sqm Barcelona Facility for QIAstat-Dx | QGEN Stock News - StockTitan
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis - GlobeNewswire
QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients - br.ADVFN.com
Qiagen (NYSE:QGEN) Shares Sold by Citigroup Inc. - MarketBeat
QIAGEN Launches Groundbreaking Custom Microbial Analysis Tools for Digital PCR & NGS - StockTitan
QIAGEN Gains FDA Clearance for Latest Respiratory Mini-Panel Test - MPO-mag
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Shareholders 23% loss in Qiagen (NYSE:QGEN) partly attributable to the company's decline in earnings over past three years - Simply Wall St
Innovations Support QIAGEN Shares Despite Macroeconomic Concerns - MSN
0.72%
자본화:
|
볼륨(24시간):